NEW YORK (GenomeWeb News) – In a patent infringement suit between Illumina and Complete Genomics, the US District Court for the Northern District of California this week denied a motion by Illumina to reconsider a judgment the court rendered in favor of Complete Genomics last October.

The October ruling found certain claims of an Illumina patent to be invalid due to prior art.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.